Switch to Spanish website/Cambie a la página web en español
CABHA certified CARF Accredited

To receive additional information about Sandhills Alternative Academy or to make a referral, please call us at: (910) 417 - 4922


Substance Abuse Intensive Outpatient Program
What is Substance Abuse Intensive Outpatient Program (SAIOP)?
This service includes structured individual and group addiction activities and services that are provided as an outpatient program designed to assist adolescent consumers to begin recovery from substance abuse and learn skills for maintaining sobriety. The program is three hours per day; three days per week for a period of 12 weeks.

SAIOP services shall include a structures program consisting of, but not limited to, the following services:
• Individual counseling and support
• Group counseling and support
• Family counseling and support
• Where appropriate, drug screens to identify recent drug use
• Strategies for relapse prevention to include community and social support systems in treatment
• Life skills
• Crisis contingency planning
• Disease management
• Treatment support activities that have been adapted or specifically designed for persons with physical disabilities, or persons with co-occurring disorders of mental
   illness and substance abuse/ dependencies or mental retardation/ developmental disability and substance abuse/ dependence.
Who is eligible for this service?
The recipient is eligible for the service when at the very least, the re is a significant substance abuse problem, leading to a mental health diagnosis. A licensed therapist will complete a comprehensive clinical assessment that demonstrates medical necessity. If qualified, the client will be approved. All relative diagnostic information shall be obtained and included in the Person Centered Plan.
What Improvements should I expect?
One expected outcome of SAIOP is abstinence (no use or abuse of drugs or alcohol). Secondary outcomes (i.e., in abstinent patients) include: sustained improvement in health and psychological functioning, reduction in any psychiatric symptoms (if present), reduction in public health and/ or safety concerns, and a reduction in the risk of relapse as evidenced by improvement in empirically supported modifiable relapse risk factors.
Right click and save as for a pdf copy of the brochure: (English)